Board of Directors & Auditors
PHASEIN's Board of Directors consist of a group of people with extensive experience in health care, finance and management.
|
|
Robert Zyzanski
Born 1952.
Founder and CEO.
Director of the Board of PHASEIN since 2002.
Founder and President & CEO of Artema Medical AB (1990 - 2000). |
| |
|
|
|
|
Anders Eckerbom
Born 1955.
Founder and Director Technology Development.
Director of the Board of PHASEIN since 2002.
Founder and R&D Manager of Artema Medical AB (1990 - 2000). |
| |
|
|
|
|
Ola Romney
Born 1959.
Director of the Board of PHASEIN since 2002.
Senior Investment Manager of SEB Företagsinvest AB since 2001.
Executive positions with SEB, Citibank (1990 - 2000).
Other assignments: Director of Cresco TiSystems NV, LipoCore AB, Index Pharmaceuticals AB. |
| |
|
|
|
|
|
Hans Andreasson
Born 1955.
Director of the Board of PHASEIN since 2009. Investment Director at SLS Invest.
Other board positions include vice chairman of the board of Oncolog Medical AB, board member of AdvanDx Inc., Atlas Antibodies AB, Gyros AB and Medical Vision AB. |
| |
|
|
 |
|
Per Carendi
Born 1948
Deputy Director of the Board of PHASEIN since 2009.
CEO of SLS Invest AB.
Other assignments: Chairman of Carmel Pharma AB and Doxa AB. Director of Exirgruppen AB and DevPort AB. |
| |
|
|
|
|
|
Ulf Lewander
Born 1966.
Deputy Director of the Board of PHASEIN since 2003. Investment Manager of SEB Företagsinvest since 1999. Account Manager of SEB Corporate Clients (1996 – 1999)
Other assignments: Director of Prodacapo AB. |
| |
|
|
|
|
Auditors
KPMG Bohlins AB, Anders Linér, Authorized Public Accountant |